We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Fresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS.
Information about the risks of taking valproate medicines during pregnancy.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the medicine piflufolastat (18F) (Pylclari) as a diagnostic tool for people with suspected or known prostate cancer.
Product Safety Report for Fabrique Par Rodis White Secret Unifying Complexion Serum presenting a serious chemical risk.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Legal requirements and good practice guidance for SQP retailers’ premises inspections.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
Guidance for the veterinary pharmaceutical industry on the production of mock-ups for assessment.
Licence and registration application information for companies that deal in precursor chemicals.
How to submit your periodic safety update report report (PSUR) or periodic benefit risk evaluation report (PBRER)
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Imposing safeguard measures for imports of certain steel products.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).